계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Laguna Pharmaceuticals
company
About
Laguna Pharmaceuticals is a biopharmaceutical company advancing vanoxerine for the treatment of atrial fibrillation.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $30M
- Industries
- Biotechnology,Health Care,Life Science
- Founded date
- Jan 1, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Active
ChanRx Corp. intends to develop and market small molecule pharmaceuticals to treat atrial fibrillation, a common arrhythmia that can cause heart attacks and strokes. The company was founded in 2008 and is based in Cleveland, Ohio.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$30M
Laguna Pharmaceuticals has raised a total of
$30M
in funding over 2 rounds. Their latest funding was raised on
Feb 17, 2015 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 17, 2015 | Series B | $30M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Laguna Pharmaceuticals is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
